Ipamorelin, a selective growth hormone secretagogue, in human pituitary testing
Journal of Clinical Endocrinology and Metabolism
2000
Study summary
Ipamorelin was assessed for selective growth hormone release in human endocrine testing.
Key findings
Ipamorelin increased GH release with greater selectivity than earlier secretagogues.
Study details
Study type
clinical study
Journal
Journal of Clinical Endocrinology and Metabolism
DOI / PubMed
10.1210/jcem.85.7.6681
Year
2000
Explore peptide profiles
Discover compounds, understand their mechanisms, and explore the research behind each peptide.
